Document:

Exhibit 10.1

 

Amendment
No. 1 to Securities PURCHASE AGREEMENT

 

This Amendment No.
1 to Securities Purchase Agreement (this “Amendment”) is effective as of June 13, 2018 by and among Sorrento
Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature
pages to this Amendment (collectively, the “Majority Purchasers”).

 

Recitals

 

Whereas,
the Company and the Majority Purchasers are parties to that certain Securities Purchase Agreement, dated as of March 26, 2018 (as
may be amended or restated from time to time, the “Purchase Agreement”), pursuant to which, among other
things, the Company agreed to issue and sell to the purchasers identified on Schedule A thereto, and such purchasers agreed to
purchase from the Company, (1) convertible promissory notes in an aggregate principal amount of $120,500,000, and (2) warrants
to purchase an aggregate of 8,591,794 shares of common stock of the Company, par value $0.0001 per share;

 

Whereas,
pursuant to Section 15 of the Purchase Agreement, no provision of the Purchase Agreement may by amended, waived or modified other
than by an instrument in writing signed by the Company and, prior to the Closing, the Purchasers purchasing at least a majority
of the aggregate principal amount of the Notes, as set forth on Schedule A thereto, and any such amendment, waiver or modification
effected in accordance with Section 15 of the Purchase Agreement shall be binding upon all Purchasers and each transferee of the
Securities, each future holder of all such securities and the Company;

 

Whereas,
as of the date of this Amendment, the Closing has not occurred;

 

Whereas,
the Majority Purchasers are Purchasers purchasing at least a majority of the aggregate principal amount of the Notes as set forth
on Schedule A to the Purchase Agreement; and

 

Whereas,
the Company and the Majority Purchasers wish to amend the Purchase Agreement to reduce the aggregate principal amount of Notes
to be issued thereunder and reduce the aggregate number of shares of Common Stock issuable upon conversion of the Warrants on the
terms set forth herein.

 

Now
Therefore, in consideration of the mutual covenants and agreements contained herein, and with reference to the above
recitals, the parties hereby agree as follows:

 

ARTICLE
1

AMENDMENTS

 

1.1       Amendment
of Recitals. The first recital of the Purchase Agreement is hereby amended by
deleting the reference to “$120,500,000” therein and replacing it with “$37,848,750” and by deleting the
reference to “8,591,794” therein and replacing it with “2,698,662”.

 

     

     

    

 

1.2       Amendment
and Restatement of Schedule A. Schedule A of the Purchase Agreement is hereby
amended and restated in its entirety to read as set forth on Exhibit 1 hereto.

 

1.3       Amendment
to Section 4.2. Section 4.2 of the Purchase Agreement is hereby amended by deleting
the reference to “$60,250,000” therein and replacing with “$18,924,375”.

 

1.4       Amendment
to Section 15 of Exhibit A. Section 15 of Exhibit A of the Purchase Agreement is hereby amended by deleting the reference to
“$115,000,000” therein and replacing with “$36,121,214”.

 

1.5       Amendment
to Section 16 of Exhibit A. Section 16 of Exhibit A of the Purchase Agreement is hereby amended by deleting the reference to
“$60,000,000” therein and replacing with “$18,845,851”.

 

1.6       Amendment
and Restatement of Schedule A to Exhibit C. Schedule A of Exhibit C of the Purchase
Agreement is hereby amended and restated in its entirety to read as set forth on Exhibit
2 hereto.

 

ARTICLE
2

GENERAL PROVISIONS

 

2.1       Definitions.
Capitalized terms in this Amendment but not otherwise defined in this Amendment shall have the meanings set forth in the Purchase
Agreement.

 

2.2       Recitals.
The Recitals shall be deemed to form part of this Amendment and are binding on the parties hereto.

 

2.3       Continuing
Effectiveness. Except as modified by this Amendment, the Purchase Agreement shall remain in full force and effect and no party
by virtue of entering into this Amendment is waiving any rights it has under the Purchase Agreement, and once this Amendment is
executed by the parties hereto, all references in the Purchase Agreement to “the Agreement” or “this Agreement,”
as applicable, shall refer to the Purchase Agreement as modified by this Amendment.

 

2.4       Successors
and Assigns. No party to this Amendment may assign any of its rights or delegate any of its obligations under this Amendment
without the prior written consent of the other parties to this Amendment. Subject to the preceding sentence, this Amendment shall
apply to, be binding in all respects upon and inure to the benefit of the successors and permitted assigns of the parties to this
Amendment.

 

2.5       Governing
Law; Venue. This Amendment, the relationship of the parties hereto and any claims or disputes arising under or relating to
this Amendment shall be governed by and construed in accordance with Section 10 of the Purchase Agreement.

 

     2

     

    

 

2.6       Counterparts.
This Amendment may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that
a .pdf or other form of electronic signature shall be considered due execution and shall be binding upon the signatory thereto
with the same force and effect as if the signature were an original, not a .pdf or other form of electronic signature.

 

[Signature Page Follows]

 

     3

     

    

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

COMPANY:

 

 

SORRENTO THERAPEUTICS, INC.

 

 

By:/s/ Henry Ji, Ph.D.

Name: Henry Ji, Ph.D.

Title: Chairman of the Board, President
& Chief Executive Officer

 

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

PURCHASER:

 

 

Asia
Pacific MedTech (BVI) Limited

 

 

 

By:/s/ GU NANA

Name: GU NANA

Title: Director

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

PURCHASER:

 

 

Famous
Sino Limited

 

 

 

By: /s/ Guangze WU

Name: Guangze WU

Title: Director

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

PURCHASER:

 

 

China In Shine Investment
Limited

 

 

 

By: /s/ CHIT FUNG

Name: CHIT FUNG

Title: Director

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

PURCHASER:

 

 

Himark
Group (Holdings) Company Limited

 

 

 

By:/s/ O Na

Name: O Na

Title: Director

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

PURCHASER:

 

 

Success
Indicator Investments Limited

 

 

 

By: /s/ Kang LI

Name: Kang LI

Title: Director

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Amendment No. 1 to Securities Purchase Agreement as of the date first written above.

 

PURCHASER:

 

 

Pipeline Ventures,
LLC

 

 

By: /s/ Patrick Lin

Name: Patrick Lin

Title: Partner

 

    
[Signature Page to Amendment No. 1 to Securities Purchase Agreement]

     

    

Exhibit
1

 

Schedule
A

 

Schedule
of Purchasers

 

	Name of Purchaser	Address	Jurisdiction of Formation (for Entities)	Principal Amount of Note Purchased	Number of Warrant Shares 
	Asia Pacific MedTech (BVI) Limited	c/o Offshore Incorporations Limited, P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands	British Virgin Islands	$10,000,000	713,012
	Famous Sino Limited	Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands	British Virgin Islands	$5,610,000	400,000
	China In Shine Investment Limited	Flat F, 12/F, Tower 5, Harbour Green, 8 Sham Mong Road, Tai Kok Tsui, Kowloon, Hong Kong	British Virgin Islands	$7,713,750	550,000
	Himark Group (Holdings) Company Limited	Flat C, 7/F, One Island Place, 51 Tanner Road, North Point, Hong Kong	British Virgin Islands	$7,012,500	500,000
	Success Indicator Investments Limited	P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands	British Virgin Islands	$7,012,500	500,000
	Pipeline Ventures, LLC	
        Pipeline Ventures, LLC

        c/o Patrick Lin

        21 “C” Orinda Way #138

        Orinda, CA 94563
	California	$500,000	35,650
	TOTAL	$37,848,750.00	2,698,662

 

Schedule A- 1

     

     

    

 

Exhibit
2

 

Schedule
A

 

Purchasers

 

	Purchaser	Contact Information for Notices	Principal Amount of Note Purchased	Shares Issuable Upon Conversion of Notes	Shares Issuable Upon Exercise of Warrants	Total Registrable Securities
	Asia Pacific MedTech (BVI) Limited	c/o Offshore Incorporations Limited, P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands	$10,000,000	1,426,024	713,012	2,139,036
	Famous Sino Limited	Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands	$5,610,000	800,000	400,000	1,200,000
	China In Shine Investment Limited	Flat F, 12/F, Tower 5, Harbour Green, 8 Sham Mong Road, Tai Kok Tsui, Kowloon, Hong Kong	$7,713,750	1,100,000	550,000	1,650,000
	Himark Group (Holdings) Company Limited	Flat C, 7/F, One Island Place, 51 Tanner Road, North Point, Hong Kong	$7,012,500	1,000,000	500,000	1,500,000
	Success Indicator Investments Limited	P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands	$7,012,500	1,000,000	500,000	1,500,000
	Pipeline Ventures, LLC	
        Pipeline Ventures, LLC

        c/o Patrick Lin

        21 “C” Orinda Way #138

        Orinda, CA 94563
	$500,000	71,301	35,650	106,951
	TOTAL	$37,848,750.00	5,397,325	2,698,662	8,095,987

 

 

Schedule A- 2EX-4.A

 Exhibit 4(a) 
  

 
  

PPL ELECTRIC UTILITIES CORPORATION 

TO 
 THE BANK OF NEW
YORK MELLON 
 Trustee 
  

 
 Supplemental
Indenture No. 20 
 Dated as of June 1, 2018 

 
  

Supplemental to the Indenture 

dated as of August 1, 2001 
  

 
 Establishing
Terms of 
 First Mortgage Bonds, 4.15% Series due 2048 
  

 
  

 SUPPLEMENTAL INDENTURE NO. 20 

SUPPLEMENTAL INDENTURE No. 20 dated as of June 1, 2018, made and entered into by and between PPL ELECTRIC UTILITIES CORPORATION, a
corporation of the Commonwealth of Pennsylvania, having its principal corporate offices at Two North Ninth Street, Allentown, Pennsylvania 18101 (hereinafter sometimes called the “Company”), and THE BANK OF NEW YORK MELLON, a New York
banking corporation, having its corporate trust office at 101 Barclay Street, 7th Floor, New York, New York 10286 (hereinafter sometimes called the “Trustee”), as Trustee under the
Indenture, dated as of August 1, 2001 (hereinafter called the “Original Indenture”), this Supplemental Indenture No. 20 being supplemental thereto. The Original Indenture and any and all indentures and instruments supplemental
thereto are hereinafter sometimes collectively called the “Indenture.” 
 RECITALS OF THE COMPANY 

The Original Indenture was authorized, executed and delivered by the Company to provide for the issuance from time to time of its Securities
(such term and all other capitalized terms used herein without definition having the meanings assigned to them in the Original Indenture), to be issued in one or more series as contemplated therein, and to provide security for the payment of the
principal of and premium, if any, and interest, if any, on such Securities. 
 The Company has heretofore executed and delivered to the
Trustee Supplemental Indentures for the purposes recited therein and for the purpose of creating series of Securities as set forth in Schedule A hereto. 

Pursuant to Article Three of the Original Indenture, the Company wishes to establish a twenty-second series of Securities, such series of
Securities to be hereinafter sometimes called “Securities of the Twenty-Second Series.” 
 Pursuant to clauses (d) and (f) of
Section 1301 and clause (g) of Section 301 of the Original Indenture, the Company wishes to modify the period during which notices of redemption may be sent with respect to the Securities of the Twenty-Second Series. 

As contemplated in Section 301 of the Original Indenture, the Company further wishes to establish the designation and certain terms of
the Securities of the Twenty-Second Series. The Company has duly authorized the execution and delivery of this Supplemental Indenture No. 20 to establish the designation and certain terms of the Securities of the Twenty-Second Series and has
duly authorized the issuance of such Securities; and all acts necessary to make this Supplemental Indenture No. 20 a valid agreement of the Company, and to make the Securities of the Twenty-Second Series valid obligations of the Company, have
been performed. 
 NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE NO. 20 WITNESSETH, that, for and in consideration of the premises and of the
purchase of the Securities by the Holders thereof, it is mutually covenanted and agreed, for the equal and proportionate benefit of the Holders of the Securities of the Twenty-Second Series, as follows: 

ARTICLE ONE 

Twenty-Second Series of Securities 

SECTION 101. There is hereby created a series of Securities designated “First Mortgage Bonds, 4.15% Series due 2048,” and the
Securities of such series shall have the terms provided therefor in this 

 
Article One of this Supplemental Indenture No. 20, shall be limited in aggregate principal amount (except as contemplated in Section 301(b) of the Original Indenture) to $400,000,000,
and shall have such terms as are hereby established for such Securities of the Twenty-Second Series as contemplated in Section 301 of the Original Indenture. The form or forms and additional terms of the Securities of the Twenty-Second Series
shall be established in an Officer’s Certificate of the Company, as contemplated by Section 201 of the Original Indenture. 

SECTION 102. Covenants. So long as any Securities of the Twenty-Second Series shall remain Outstanding, the following shall be an
additional covenant of the Company under the Indenture: So long as any Securities of the Twenty-Second Series shall remain Outstanding, the Company shall not cause or permit the Release Date to be established, as contemplated in Section 1811 of
the Original Indenture. 
 SECTION 103. Amendment. With respect to the Securities of the Twenty-Second Series, notwithstanding the
first sentence of Section 504 of the Original Indenture, notice of redemption of the Securities of the Twenty-Second Series shall be given in the manner provided in Section 109 of the Original Indenture to the Holders of such Securities to
be redeemed not less than 10 nor more than 60 days prior to the Redemption Date. 
 SECTION 104. Satisfaction and Discharge. The
Company hereby agrees that, if the Company shall make any deposit of money and/or Eligible Obligations with respect to any Securities of the Twenty-Second Series, or any portion of the principal amount thereof, as contemplated by Section 801 of
the Indenture, the Company shall not deliver an Officer’s Certificate described in clause (z) in the first paragraph of said Section 801 unless the Company shall also deliver to the Trustee, together with such Officer’s
Certificate, either: 
 (a) an instrument wherein the Company, notwithstanding the satisfaction and discharge of its indebtedness in respect
of such Securities, shall retain the obligation (which shall be absolute and unconditional) irrevocably to deposit with the Trustee or Paying Agent such additional sums of money, if any, or additional Eligible Obligations (meeting the requirements
of Section 801), if any, or any combination thereof, at such time or times, as shall be necessary, together with the money and/or Eligible Obligations theretofore so deposited, to pay when due the principal of and premium, if any, and interest
due and to become due on such Securities or portions thereof, all in accordance with and subject to the provisions of said Section 801; provided, however, that such instrument may state that the obligation of the Company to make additional
deposits as aforesaid shall be subject to the delivery to the Company by the Trustee of a notice asserting the deficiency accompanied by an opinion of an independent public accountant of nationally recognized standing, selected by the Trustee,
showing the calculation thereof (which opinion shall be obtained at the expense of the Company); or 
 (b) an Opinion of Counsel to the
effect that the Holders of such Securities, or portions of the principal amount thereof, will not recognize income, gain or loss for United States federal income tax purposes as a result of the satisfaction and discharge of the Company’s
indebtedness in respect thereof and will be subject to United States federal income tax on the same amounts, at the same times and in the same manner as if such satisfaction and discharge had not been effected. 

ARTICLE TWO 

Miscellaneous Provisions 

SECTION 201. This Supplemental Indenture No. 20 is a supplement to the Original Indenture, as heretofore amended and supplemented.
As supplemented by this Supplemental Indenture No. 20, the Original Indenture, as heretofore amended and supplemented, is in all respects ratified, approved and 

  
 2 

 
confirmed, and the Original Indenture, as heretofore amended and supplemented, and this Supplemental Indenture No. 20 shall together constitute the Indenture. 

SECTION 202. The recitals contained in this Supplemental Indenture No. 20 shall be taken as the statements of the Company, and the
Trustee assumes no responsibility for their correctness and makes no representations as to the validity or sufficiency of this Supplemental Indenture No. 20. 

This instrument may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such
counterparts shall together constitute but one and the same instrument. 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture No. 20 to be
duly executed on the 12th day of June, 2018. 
  

			
	PPL ELECTRIC UTILITIES CORPORATION
		
	By:	 	             /s/ Tadd J. Henninger
		 	Name:  Tadd J. Henninger
		 	Title:    Treasurer

 [Signature Page to Supplemental Indenture No. 20] 

 
			
	THE BANK OF NEW YORK MELLON, as Trustee
		
	By:	 	             /s/ Francine Kincaid
		 	Name:  Francine Kincaid
		 	Title:    Vice President

 [Signature Page to Supplemental Indenture No. 20] 

			
	COMMONWEALTH OF PENNSYLVANIA	 	    )
		 	    )    ss.:
	COUNTY OF LEHIGH	 	    )

 On this 12th day of June, 2018, before me, a notary public, the undersigned, personally appeared Tadd J.
Henninger, who acknowledged himself to be the Treasurer of PPL ELECTRIC UTILITIES CORPORATION, a corporation of the Commonwealth of Pennsylvania and that he, as such Treasurer, being authorized to do so, executed the foregoing instrument for the
purposes therein contained, by signing the name of the corporation by himself as Treasurer. 
 In witness whereof, I hereunto set my hand
and official seal. 
  

	
	/s/ Jacqueline M. Jacob
	 Notary Public
  

[Seal]

			
	STATE OF NEW YORK	 	    )
		 	    )    ss.:
	COUNTY OF NEW YORK	 	    )

 On this 11th day of June, 2018, before me, a notary public, the undersigned, personally appeared Francine
Kincaid, who acknowledged herself to be a Vice President of THE BANK OF NEW YORK MELLON, a corporation and that she, as Vice President, being authorized to do so, executed the foregoing instrument for the purposes therein contained, by signing the
name of the corporation by herself as Vice President. 
 In witness whereof, I hereunto set my hand and official seal. 

 

	
	/s/ Tamara L. Wolbers
	 Tamara L. Wolbers
 Notary Public – State
of New York
 No. 01WO6177935
 Qualified in Nassau County

Commission Expires 11/19/2019
  

[Seal]

 The Bank of New York Mellon hereby certifies that its precise name and address as Trustee hereunder are:

 The Bank of New York Mellon 

101 Barclay Street, 7th Floor 

New York, New York 10286 
 Attn:
Corporate Trust Administration 
  

			
	THE BANK OF NEW YORK MELLON, as Trustee
		
	By:	 	             /s/ Francine Kincaid
		 	Name:  Francine Kincaid
		 	Title:    Vice President

 SCHEDULE A 
  

																			
	 Supplemental

Indenture No.
	  	 Dated as of
	  	 Series
	  	 Series Designation
	  	Principal
Amount
Authorized	 	  	Principal
Amount Issued	 	  	Principal
Amount
Outstanding1	 
	 1
	  	August 1, 2001	  	First	  	 Senior Secured Bonds,

5 7/8% Series due 2007
	  	$	300,000,000	 	  	$	300,000,000	 	  	 	None	 
	 1
	  	August 1, 2001	  	Second	  	Senior Secured bonds,
6  1⁄4% Series due 2009	  	$	500,000,000	 	  	$	500,000,000	 	  	 	None	 
	 2
	  	February 1, 2003	  	Third	  	 Senior Secured Bonds, 3.125%

Pollution Control Series due 2008
	  	$	90,000,000	 	  	$	90,000,000	 	  	 	None	 
	 3
	  	May 1, 2003	  	Fourth	  	 Senior Secured Bonds, 4.30%

Series due 2013
	  	$	100,000,000	 	  	$	100,000,000	 	  	 	None	 
	 4
	  	February 1, 2005	  	Fifth	  	 Senior Secured Bonds, 4.70%

Pollution Control Series due 2029
	  	$	115,500,000	 	  	$	115,500,000	 	  	 	None	 
	 5
	  	May 1, 2005	  	Sixth	  	 Senior Secured Bonds, 4.75%

Pollution Control Series due 2027
	  	$	108,250,000	 	  	$	108,250,000	 	  	 	None	 
	 6
	  	December 1, 2005	  	Seventh	  	 Senior Secured Bonds, 4.95%

Series due 2015
	  	$	100,000,000	 	  	$	100,000,000	 	  	 	None	 
	 6
	  	December 1, 2005	  	Eighth	  	 Senior Secured Bonds, 5.15%

Series due 2020
	  	$	100,000,000	 	  	$	100,000,000	 	  	$	100,000,000	 
	 7
	  	August 1, 2007	  	Ninth	  	 Senior Secured Bonds, 6.45%

Series due 2037
	  	$	250,000,000	 	  	$	250,000,000	 	  	$	250,000,000	 
	 8
	  	October 1, 2008	  	Tenth	  	 Senior Secured Bonds, 7.125%

Series due 2013
	  	$	400,000,000	 	  	$	400,000,000	 	  	 	None	 
	 9
	  	October 1, 2008	  	Eleventh	  	Senior Secured Bonds, Variable Rate Pollution Control Series 2008	  	$	90,000,000	 	  	$	90,000,000	 	  	$	90,000,000	 
	 10
	  	May 1, 2009	  	Twelfth	  	 First Mortgage Bonds, 6.25%

Series due 2039
	  	$	300,000,000	 	  	$	300,000,000	 	  	$	300,000,000	 
	 11
	  	July 1, 20112	  	—	  	—	  	 	—  	 	  	 	—  	 	  	 	—  	 
	 12
	  	July 1, 2011	  	Thirteenth	  	 First Mortgage Bonds, 5.20%

Series due 2041
	  	$	250,000,000	 	  	$	250,000,000	 	  	$	250,000,000	 
	 13
	  	August 1, 2011	  	Fourteenth	  	 First Mortgage Bonds, 3.00%

Series due 2021
	  	$	400,000,000	 	  	$	400,000,000	 	  	$	400,000,000	 
	 14
	  	August 1, 2012	  	Fifteenth	  	 First Mortgage Bonds, 2.50%

Series due 2022
	  	$	250,000,000	 	  	$	250,000,000	 	  	$	250,000,000	 
	 15
	  	July 1, 2013	  	Sixteenth	  	 First Mortgage Bonds, 4.75%

Series due 2043
	  	$	350,000,000	 	  	$	350,000,000	 	  	$	350,000,000	 
	 16
	  	June 1, 2014	  	Seventeenth	  	 First Mortgage Bonds, 4.125%

Series due 2044
	  	$	300,000,000	 	  	$	300,000,000	 	  	$	300,000,000	 
	 17
	  	October 1, 2015	  	Eighteenth	  	 First Mortgage Bonds, 4.15%

Series due 2045
	  	$	350,000,000	 	  	$	350,000,000	 	  	$	350,000,000	 

  
  

	1 	As of June 1, 2018. 

	2 	Supplemental Indenture No. 11 provided for certain amendments to the Original Indenture and did not provide for the establishment of any series of Securities. 

  
 A-1 

																			
	 18
	  	March 1, 2016	  	Nineteenth	  	 First Mortgage Bonds, Pollution

Control Series 2016A
	  	$	115,500,000	 	  	$	115,500,000	 	  	$	115,500,000	 
	 18
	  	March 1, 2016	  	Twentieth	  	 First Mortgage Bonds, Pollution

Control Series 2016B
	  	$	108,250,000	 	  	$	108,250,000	 	  	$	108,250,000	 
	 19
	  	May 1, 2017	  	Twenty-First	  	 First Mortgage Bonds, 3.950%

Series due 2047
	  	$	475,000,000	 	  	$	475,000,000	 	  	$	475,000,000	 

  
 A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]